Allergan Plc

AbbVie Inc (NYSE:ABBV) Plans To Keep Allergan’s (NYSE:AGN) Aesthetic Business As An Independent Unit

AbbVie Inc (NYSE:ABBV) and Allergan Plc (NYSE:AGN) have been working on the finer details of their $63 billion merger. The company has come up with an integration plan, and it is planning to keep Allergan’s aesthetic business as an independent unit. AbbVie to keep Allegan Aesthetics as an independent unit The Allergan Aesthetics unit will […]

The US FDA Approves Allergan Plc (NYSE:AGN)’s Ubrogepant To Cure Migraine In Adults: Allergan Expects to Launch Ubrogepant In Q1 2020

Allergan Plc (NYSE:AGN) has received the nod of the US FDA for its innovative drug – Ubrogepant to cure migraines in adults. The new drugs work by blocking the CGRP (calcitonin gene-related peptide) and offers relief for people suffering from migraine. Allergan expects to introduce Ubrogepant in Q1 2020 to treat migraines. According to the […]